[1]
“Review of International Approaches to Assessing and Financing Tumor-agnostic Drugs ”, Вопр. онкол., vol. 69, no. 5, pp. 805–814, Nov. 2023, doi: 10.37469/0507-3758-2023-69-5-805-814.